Leaderboards/Esophageal Cancer Research and Treatment

Esophageal Cancer Research and Treatment

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Ben M. Eyck
Erasmus MC Cancer Institute
2
Berend J. van der Wilk
Erasmus MC Cancer Institute
3
Anders B. Dohlman
Dana-Farber Cancer Institute
4
Weiqiu Jin
University of Electronic Science and Technology of China
5
Kiki Fockens
Amsterdam Neuroscience
6
Marianne C. Kalff
Amsterdam University Medical Centers
7
Yingbo Qu
Chongqing University of Technology
8
Charlène J. van der Zijden
Erasmus MC Cancer Institute
9
Qianwei Jiang
Zhejiang Cancer Hospital
10
Shahriar A. Zamani
National Cancer Institute

Papers

1
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial
The Lancet Oncology|2025
90 cit.
2
Burdens of stomach and esophageal cancer from 1990 to 2019 and projection to 2030 in China: Findings from the 2019 Global Burden of Disease Study
Journal of Global Health|2024
61 cit.
3
Publication in Gastrointestinal Endoscopy (2024) [12 citations, W4394602681]
Gastrointestinal Endoscopy|2024
12 cit.
4
Publication in Diseases of the Esophagus (2024) [10 citations, W4399352461]
Diseases of the Esophagus|2024
10 cit.
5
Publication in European Journal of Surgical Oncology (2024) [3 citations, W4390817736]
European Journal of Surgical Oncology|2024
3 cit.
6
Publication in Annals of Surgical Oncology (2024) [3 citations, W4391057867]
Annals of Surgical Oncology|2024
3 cit.
7
Publication in Annals of Surgical Oncology (2024) [3 citations, W4396746998]
Annals of Surgical Oncology|2024
3 cit.
8
Publication in Clinical Colorectal Cancer (2024) [2 citations, W4393972502]
Clinical Colorectal Cancer|2024
2 cit.
9
Publication in Digestive Surgery (2024) [2 citations, W4401321660]
Digestive Surgery|2024
2 cit.
10
Publication in Cell (2026) [2 citations, W7160304102]
Cell|2026
2 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Lenora A. Pluchino
National Comprehensive Cancer Network
2
Madhan Kumar Kuppusamy
Virginia Mason Medical Center
3
Stephen L. Riche
Unknown
4
Elizabeth Smyth
National Health Service
5
Stella Mook
Utrecht University
6
Roos E. Pouw
Utrecht University
7
Feng Wang
Nanjing Medical University
8
Yating Sun
Obstetrics and Gynecology Hospital of Fudan University
9
Xiaogang Liu
Tongji University
10
Lucas Goense
St. Antonius Ziekenhuis

Papers

1
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2022
1.7k cit.
2
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology|2022
1.4k cit.
3
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology|2022
656 cit.
4
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial
Cancer Cell|2022
565 cit.
5
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2023
520 cit.
6
Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Endoscopy|2023
183 cit.
7
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer
ESMO Open|2024
90 cit.
8
NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022
Journal of the National Comprehensive Cancer Network|2022
76 cit.
9
Evaluation of International Contemporary Operative Outcomes and Management Trends Associated With Esophagectomy: A 4-Year Study of >6000 Patients Using ECCG Definitions and the Online Esodata Database.
PubMed|2022
53 cit.
10
Endoscopic vacuum therapy for esophageal perforation: a multicenter retrospective cohort study
Endoscopy|2023
37 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Ahmedin Jemal
American Cancer Society
2
Jacques Bergman
University of Amsterdam
3
Ate van der Gaast
Erasmus MC
4
Tom R. DeMeester
University of Southern California
5
Yuko Kitagawa
Keio University
6
J. Jan B. van Lanschot
Erasmus MC Cancer Institute
7
Rebecca C. Fitzgerald
Cancer Research UK
8
K. Yokoi
Saga University
9
Trond‐Eirik Strand
UiT The Arctic University of Norway
10
Richard van Hillegersberg
University Medical Center Utrecht

Papers

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
CA A Cancer Journal for Clinicians|2018
87.7k cit.
2
Global cancer statistics
CA A Cancer Journal for Clinicians|2011
55k cit.
3
Global cancer statistics, 2012
CA A Cancer Journal for Clinicians|2015
27.4k cit.
4
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
CA A Cancer Journal for Clinicians|2024
23.1k cit.
5
Cancer statistics, 2020
CA A Cancer Journal for Clinicians|2020
21.4k cit.
6
Cancer statistics, 2019
CA A Cancer Journal for Clinicians|2019
21k cit.
7
Cancer statistics, 2022
CA A Cancer Journal for Clinicians|2022
18.2k cit.
8
Cancer Statistics, 2021
CA A Cancer Journal for Clinicians|2021
17.4k cit.
9
Cancer statistics, 2018
CA A Cancer Journal for Clinicians|2018
17k cit.
10
Cancer statistics, 2023
CA A Cancer Journal for Clinicians|2023
16.7k cit.

Reagents for Esophageal Cancer Research and Treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 70

CD8 alpha (D8A8Y) Rabbit Monoclonal Antibody

#85336$166,369
View Evidence →
Cell Signaling TechnologyEvidence 65

alpha-Parvin (D7F9) Rabbit Monoclonal Antibody

#8190$175,384
View Evidence →
Agilent/Dako

Actin (Smooth Muscle)/ACTA2

#M085129-2
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

mTOR Regulation Antibody Sampler Kit

Cited in 8 papers
#9864$581
View Evidence →
Cell Signaling TechnologyEvidence 65

Stat3 (D3Z2G) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 555 Conjugate)

Cited in 5 papers
#47532$458
View Evidence →
Cell Signaling TechnologyEvidence 67

P-Cadherin (C13F9) Rabbit Monoclonal Antibody

#2189$152,351
View Evidence →